USFDA Withdrwas Sales Ban as Indian Pharma Companies Take Corrective Measures
A new recommendation has come in for the Indian drug companies. Most Indian drug companies that were penalised for violating […]
Tags: Aurobindo Pharma Ltd, Cadila Healthcare, cancer, Centrum Broking, CEO, Claris Lifesciences Limited, DAIICHI SANKYO COMPANY LIMITED, Daiichi-Sankyo, drug maker, food and drug administration, Health/Medical/Pharmaceuticals, Hyderabad, India, lower healthcare cost, manufacturing norms, manufacturing processes, pharmaceutical, Pharmaceutical sciences, Pharmacology, Ranbaxy Laboratories, Secretary General, Sun Pharmaceuticals Industries Ltd, United States, USD, utive
Sun Pharma Eyeing German Drug Firm
Sun Pharmaceutical Industries Ltd is eyeing a possible takeover of German generic drug maker Stada Arzneimittel AG. Sun has sought […]
Wockhardt hiving off R&D business
Drug maker Wockhardt has announced it will spin off its R&D business and list the new company on stock exchange on January 1, 2009. The company thus has followed similar moves by other pharma companies, who have hived off their research and development units.
Blogs new window to the world for Pharma industry
Pharma blogs are playing an important role in shaping the future of the pharmaceutical industry in India. Many Indian online financial portal and investment firms as well as research organisations have provided a blogging platform for the pharma industry to keep itself updated with the development in the pharma world through open and uncensored discussion.
CRAMS to global pharma companies, give good returns
The pharma sector may have underperformed in the Sensex , but companies providing contract research and manufacturing services (CRAMS) to global pharma companies have given good returns.
